A new γ-secretase modulators with an Aminothiazole core starting from a HTS hit is disclosed . Also, synthesis and SAR of this series are discussed.
These novel compounds demonstrate moderate to good in vitro potency in inhibiting amyloid beta (Aβ) peptide production.
Overall γ-secretase is not inhibited but the formation of the aggregating, toxic Aβ42 peptide is shifted to smaller non-aggregating Aβ peptides. Compound 15 reduced brain Aβ42 in vivo in APPSwe transgenic mice at 30 mg/kg p.o.
0 件のコメント:
コメントを投稿